Purchase Order 12444026P0174
Award Date 9/15/26
Potential Completion Date 10/31/26
Potential Value $148K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX 77843, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of Olink Explore HT Reagent Kits, specialized biological and reagent materials used in advanced proteomics research. The contract has a ceiling value of $24,961.31 and a period of performance through September 17, 2025. Olink...
- <p>The NIH Clinical Center awarded a purchase order to Olink Proteomics Inc. for Olink reagents valued at $24,607.29, effective July 1, 2026, with completion by September 30, 2026. Performance occurs in Waltham, Massachusetts. The order is firm fixed price with no small business set-aside.</p>
- This is a firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for the provision of Olink Target 96 reagent kits. The contract has a ceiling value of $37,484.25 and a performance period ending on July 14, 2025. Olink Proteomics specializes in innovative protein biomarker discovery solutions for various research areas, including aging, cancer, neurodegenerative diseases, diabetes, and infectious...
- This is a $30,625.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for Olink's EXPLORE HT proteomics analysis service, which provides high-multiplex protein biomarker discovery capabilities. Olink Proteomics has a history of providing proteomics instruments, reagents, and analysis services to...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a $198,740.56 firm fixed price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for Olink Explore 3072 reagent kits. The contract is for the delivery of these reagents by September 6, 2023. Olink Proteomics has a history of providing various proteomics instruments, reagents, kits, analysis services,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging awarded a firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for an EXPLORE 3072 Reagent Kit. The contract has a potential value of $184,037.60 and a completion date of August 31, 2022. Olink Proteomics has been awarded numerous federal contracts from agencies such as NIH, FDA, and Department of Veterans Affairs to...
- This federal contract award, valued at $24,775.29, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company located in Waltham, Massachusetts. The contract requires Olink to provide proteomic kits to isolate and quantify proteins in plasma and bronchiole alveolar lavage samples. This is a firm fixed-price purchase order contract with a completion...
- Olink Proteomics AB was awarded a firm fixed price, indefinite delivery contract valued at up to $1,214,788 by the National Institutes of Health National Institute on Drug Abuse to provide biological and reagent materials as well as proteomics analysis services. Specializing in proprietary multiplex protein biomarker analysis technologies, Olink will support biomedical research efforts through delivery of Olink Explore and Target multiplex protein analysis kits, reagents, array chips, and...
- The National Institute of Environmental Health Sciences awarded a purchase order to Olink Proteomics AB valued at $114,080 on September 15, 2021, for Onlink Target 96 Inflammation Analysis Service. Performance occurred in Sweden from September 15, 2021 through June 15, 2022. The order was issued as a simplified acquisition without set-aside, priced on a firm fixed price basis. The purchase order supported the de-obligation of expiring fiscal year 2021 funding in preparation for the September 30,...